Takeda Pharmaceutical TAK
NYSE TAK
$18.19 -0.33 (-1.78%)
At close: Sep 30, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Accounts Payables (2017 - 2026)

Updated

Takeda Pharmaceutical's Accounts Payables came in at $2.8 billion for the quarter ended Jun 30, 2026, down 3.7% from $2.91 billion a year earlier and down 10.5% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Accounts Payables (2017 - 2026) Analysis & Trends

As of Mar 31, 2026, Takeda Pharmaceutical's Accounts Payables was $3.26 billion, up 4.6% from the prior year.

  • Accounts Payables carries a five-year compound annual growth rate of 0.1% (years ended Mar 2021 to Mar 2026).
  • Going back by year, Accounts Payables was $3.12 billion in the year ended Mar 31, 2025 (-17.8%), $3.8 billion in the year ended Mar 31, 2024 (-21.0%), $4.81 billion in the year ended Mar 31, 2023 (+4.5%) and $4.6 billion in the year ended Mar 31, 2022 (+41.8%).
  • The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Accounts Payables since the quarter ended Sep 30, 2024.
  • Year-over-year, Accounts Payables increased in three of the last eight quarters, with an average decline of 3.3%.
  • The fastest year-over-year change in Accounts Payables over five years came in the quarter ended Mar 31, 2022 (growth of 36.8%), and the weakest in the quarter ended Mar 31, 2024 (a decline of 24.7%).
  • Business Quant data shows TAK's Accounts Payables at $3.13 billion (quarter ended Mar 31, 2026), $3.04 billion (quarter ended Dec 31, 2025) and $2.98 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn 2.80 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.80 Bn
Mar 31, 2026 3.13 Bn
Dec 31, 2025 3.04 Bn
Sep 30, 2025 2.98 Bn
Jun 30, 2025 2.91 Bn
Mar 31, 2025 3.12 Bn
Dec 31, 2024 3.03 Bn
Sep 30, 2024 2.77 Bn
Jun 30, 2024 3.01 Bn
Mar 31, 2024 3.69 Bn
Dec 31, 2023 3.27 Bn
Sep 30, 2023 2.92 Bn
Jun 30, 2023 3.22 Bn
Mar 31, 2023 4.91 Bn
Dec 31, 2022 2.70 Bn
Sep 30, 2022 2.81 Bn
Jun 30, 2022 3.28 Bn
Mar 31, 2022 4.44 Bn
Jun 30, 2021 2.93 Bn
Mar 31, 2021 3.25 Bn
API Access

Takeda Pharmaceutical Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=TAK&period=max&api_key=YOUR_API_KEY